 |
|
|
| |
Sustained Viral Suppression among Participants with Pre-existing M184V/I Who Switched to Bictegravir/Emtricitabine/TenofovirAlafenamide
|
| |
| |
117th European AIDS Conference (EACS), 6-9 November 2019, Basel, Switzerland
Reported by Jules Levin
Kristen Andreatta, Rima Acosta, Michelle L. D'Antoni, Danielle P. Porter, Silvia Chang, Ross Martin, Madeleine Willkom, Hui Lui, Ian McNicholl, Joel Gallant, Cheryl Pikora, Hiba Graham, Sean Collins, Hal Martin, and Kirsten L. White
Gilead Sciences, Foster City, CA, 94404
|
| |
|
|
|
|
|
